Graft Versus Host Disease clinical trials

Explore recruiting graft versus host disease clinical trials.

Recruiting graft versus host disease studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Graft Versus Host Disease trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Fecal Microbiota Transplantation in the prevention of complications after allogeneic hematopoietic stem cell transplantation for hematologic malignancy

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Phase II Clinical Trial to optimize the dose of an anti-NKG2A monoclonal antibody (humZ270 mAb, IPH2201) for patients with acute myeloid leukemia or myelodysplastic syndrome undergoing haploidentical transplantation with post-transplantation cyclophosphamide.

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Phase 2 Trial to determine the safety and efficacy of simultaneous treatment with ruxolitinib and extracorporeal photopheresis for patients with steroid-refractory chronic Graft-versus-Host-Disease (SR-cGvHD) - RUX-ECP

Germany, Austria

Therapeutic exploratory (Phase II) EU CTIS Study details

Phase 2 Trial to determine the efficacy of belumosudil for patients with steroid-refractory overlap of syndrome Graft-versus-Host-Disease (SR-osGVHD) - BEAT-GVHD

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

ALL SCTped 2012 FORUM - Allogeneic Stem Cell Transplantation in Children and Adolescents with Acute Lymphoblastic Leukaemia

Italy, Norway, Slovakia, Austria, Belgium, Germany +6 more

Phase II and Phase III (Integrated) EU CTIS Study details

Phase I-Ib clinical trial of safety and immunobiology of prophylactic infusion of lymphocytes and NK cells after Allo-HCT.

Spain

Human Pharmacology (Phase I)- Other EU CTIS Study details

Graft Versus Host Disease trials by city

Graft Versus Host Disease in Toronto Graft Versus Host Disease in Vancouver Graft Versus Host Disease in Montreal Graft Versus Host Disease in Calgary Graft Versus Host Disease in Edmonton Graft Versus Host Disease in Ottawa Graft Versus Host Disease in Winnipeg Graft Versus Host Disease in Quebec City Graft Versus Host Disease in Hamilton Graft Versus Host Disease in Kitchener Graft Versus Host Disease in London Graft Versus Host Disease in Halifax Graft Versus Host Disease in New York Graft Versus Host Disease in Los Angeles Graft Versus Host Disease in Chicago Graft Versus Host Disease in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease